Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer

Fig. 2

The clinical significance of PSAT1 overexpression in ER-negative breast cancer patients. The expression levels of PSAT1 in ER-negative breast cancers were divided according to tumor size (a) and the number of lymph node metastases (b). (*P < 0.05) (c) Kaplan-Meier survival analyses show that high expression of PSAT1 is correlated with poor survival (n = 297; *P < 0.05, log-rank test)

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us